Los Angeles County Department of Public Health Tuberculosis Control Program
2615 So. Grand Avenue, Room 507 Los Angeles, Calif. 90007 Phone: (213) 745-0800




“TB Drugs and Hepatotoxicity” and “TB Case Presentations”

Friday, October 4, 2013
Ferguson Complex 
5555 Ferguson Drive, Auditorium
City of Commerce, California 90022
9:05 a.m. – 10:20 a.m.  (Part 1, Lecture with Q and A)
10:30 a.m. – 11:30 a.m.  (Part 2, TB Case Presentations)

8:30 am – 9:00 am        Registration and Sign-In
9:00 am – 9:05 am        Welcome and Program Overview
Robert Miodovski, M.P.H.
Senior Health Educator, TB Control Program
9:05 am –10:05 am       Part I – “TB Drugs and Hepatotoxicity”    (1 hour C.M.E. credit)
Andrew Stolz, M.D.
Associate Professor of Medicine
Director, Molecular Biology Core, Research Center for Liver Diseases
LAC+USC Medical Center
10:05 am – 10:20 am     Questions and Answers
10:20 am – 10:30 am    Break
10:30 am – 11:30 am     Part 2 – TB Case Presentations    (1 hour C.M.E. credit)
Steven Hwang, M.D.
Facilitator, Assistant Director, TB Control Program
11:30 am                         Submission of Evaluations

This conference is designed to provide the clinician with a comprehensive overview of the problem of TB drug-induced hepatotoxicity, including its incidence, the basic science of liver physiology and theory of the mechanisms of drug-induced liver injury, and the approach to the clinical management of this common problem.  Case presentations will follow the lecture.

Educational Objectives:

At the conclusion of the lecture, participants will be able to:

  1. Describe the epidemiology of drug-induced hepatotoxicity in the treatment of TB disease and latent TB infection
  2. Explain the basic principles and theory of liver physiology and drug-induced hepatotoxicity
  3. Describe the recommended clinical approach to the patient with drug-induced hepatotoxicity while being treated for active TB disease and latent TB infection
  4. Explain how effective patient education and close patient-provider communication are essential in the early detection and timely management of TB drug induced hepatotoxicity

At the conclusion of TB Case Presentations, participants will be able to:

  1. Identify significant findings and changes in radiographs of patients with suspected or confirmed tuberculosis
  2. Apply the latest ATS/CDC recommendations regarding treatment.
  3. Identify at least one cultural or linguistic concern pertinent to the cases presented that is brought out during the group discussion.

Educational Methods: 

Educational methods will include a lecture, case presentations, review of radiographs, and a question and answer session.

Target Audience:

This activity is applicable for physicians, particularly those who work in CHS TB clinics.  Other groups who are encouraged to attend include nurses, epidemiologists, public health investigators, and health educators.


Parking at the Ferguson Complex is free

Physicians:  The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

The Los Angeles County Department of Public Health designates this live activity for a maximum of [2] AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

Nurses:  Nurses receive a Certificate of attendance.  This activity is designated for [ 2 ] AMA PRA Category 1 Credit(s)™  which is recognized by the California Board of Registered Nursing toward license renewal for registered nurses.  (There is no CME provider number.)

Participants arriving more than 15 minutes late for a one-hour program or 30 minutes or more for a two-hour program will not be granted a CME certificate. There will be no partial credit granted for those who leave early.

Voluntary Request for Reasonable Accommodation (ADA):  Individuals with special needs should contact the activity coordinator 10 working days in advance of the activity for assistance.  Reference; ADA, July 26, 1990 (Public Law 101-366), Title 1, 11, 11 & IV

Your suggestions for future activities are welcome.  For questions or further information, please contact:
Robert Miodovski, M.P.H., Sr. Health Educator, Tuberculosis Control Program
Tel. # 213-745-0801   Fax # 213-749-0926 E-mail address: rmiodovs@ph.lacounty.gov


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s